We are monitoring the impact of COVID-19 on Neurostimulation Devices Market Get in touch with us for detailed analysis Know More
Pulished Date December, 2020
ID: 10613
Share on
Share on

Global Neurostimulation Devices Market Size, Share, Trends & Growth Analysis Report – Segmented By Technology, Application and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Industry Forecast (2020 to 2025)

Pulished: December, 2020
ID: 10613
Pages: 190

Neurostimulation Devices Market Size (2020 to 2025)

The size of the global neurostimulation devices market has been estimated at USD 9.89 billion in 2020 and is forecasted to rise at a CAGR of 17.2% CAGR between 2020 to 2025.

Y-O-Y growth in the prevalence of diseases related to lifestyles like depression and chronic pain is significantly driving the growth of the global neurostimulation devices market. The growing incidence in the numerous neurological disorders, the rapid rise in investments for R&D neurology, a surge in demand for minimally invasive surgery, growth in the adoption rate in products of advanced technology, and the increase of the aged population are additional factors supporting the development in this market.

The global neurostimulation devices market is providing many lucrative opportunities for emerging countries. Usage of neurostimulators to manage devices for ongoing diseases like interstitial cystitis, asthma, and obsessive-compulsive disorders offers emerging nations an opportunity to propel in the global neurostimulation devices market.

The global neurostimulation devices market is majorly restrained by the association of allergic reaction with devices like tingle or prickles on the skin, the rise of high expenditure on devices, and the availability of other treatment procedures like drug therapies and surgeries.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Technology, Application and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bristol-Myers Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi Sankyo, and Pfizer Inc.

 

This research report on the global neurostimulation devices market has been segmented and sub-segmented based on the technology, application, and region.

Neurostimulation Devices Market - By Technology:

  • Internal Neuromodulation
  • External Neuromodulation

Based on the technology, the internal neuromodulation segment accounted for the largest share due to factors such as the advanced technology that is currently undergoing an experimental phase and the usage of advanced devices to treat diseases like Alzheimer's, refractory epilepsy, cluster headache, Tourette syndrome, movement of disorders by multiple sclerosis, and trigeminal neuralgia. The rise of awareness about devices among the public is likely to boost sales in this market during the forecast period.

Neurostimulation Devices Market - By Application:

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

Based on the application, Parkinson’s treatment of the deep brain stimulation segment is holding the largest share and a high compound annual growth rate due to the rise in incidences and the growth of R&D activities worldwide.

Neurostimulation Devices Market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • Italy
    • Spain
    • France
    • Rest of EU
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • New Zealand
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Rest of Latin America
  • The Middle East and Africa

Geographically, North American is likely to account for the largest share with dominancy during the forecast period due to attributing factors like the harsh government regulations and rapid increase in average numerous days due to requirement of FDA approvals. Following the North American region, the European region is accounting for the second-largest revenue rate due to the presence of rapid economic development and obtaining government approvals in an easy way than FDA approvals. The Asia-Pacific region is also estimated to develop with an outstanding fast revenue share during the foreseen period. Some of the attributing factors are the growth of the geriatric population and medical needs in this locale. Moreover, economically developing countries like China and India and the rise in expenditure on healthcare will further boost the local industry.

KEY MARKET PLAYERS:

Notable market participants dominating the global neurostimulation devices market are Abbott, Bayer AG, Boston Scientific Corporation, IntraPace, Inc., Laborie, Inc., LivaNova PLC, Medtronic, Neuronetics, Inc., NuroPace Inc., Nevro Corp., and SPR Therapeutics.

KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • In 2019, a partnership was made by NeuroSigma with Teijin Limited in Japan. This partnership helps to have exclusive rights of the core company of Teijin healthcare business.
  • In 2018, an agreement was made by Abbot with the National Institutes of Health (NIH) in the US. Abbott will provide information on neuromodulation technologies, including directional SCS, DRG, and DBS therapies, to explore the application of chronic pains with progressive movement disorders.
  • In 2017, an agreement about a partnership was made by Medtronic with Mercy in the US for establishing a new data sharing and analysis network to gather clinical shreds of evidence for medical device innovation and access to patients.  
  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. By Technology
      1. Internal Neuromodulation
      2. External Neuromodulation
      3. Y-o-Y Growth Analysis, By Technology
      4. Market Attractiveness Analysis, By Technology
      5. Market Share Analysis, By Technology
    2. By Application
      1. Spinal Cord Stimulation
      2. Deep Brain Stimulation
      3. Sacral Nerve Stimulation
      4. Gastric Electrical Stimulation
      5. Transcutaneous Electrical Nerve Stimulation
      6. Transcranial Magnetic Stimulation
      7. Respiratory Electrical Stimulation
      8. Y-o-Y Growth Analysis, By Application
      9. Market Attractiveness Analysis, By Application
      10. Market Share Analysis, By Application
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. North America
      1. Introduction
      2. United States
      3. Canada
    3. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
      7. Rest of Europe
    4. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    6. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. Africa
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Abbott
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Bayer AG
    3. Boston Scientific Corporation
    4. IntraPace, Inc.
    5. Laborie, Inc.
    6. LivaNova PLC
    7. Medtronic
    8. Neuronetics, Inc.
    9. NuroPace Inc.
    10. Nevro Corp.
    11. SPR Therapeutics
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
  13. List of Tables
  14. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of technology and application along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

Neurostimulation Devices Market

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample